Rotavirus vaccine implementation: evidence to fill the gap?
作者信息
Buttery Jim P, Kirkwood Carl
机构信息
Centre for Health Analytics, Royal Children's Hospital, Murdoch Childrens Research institute, Department of Paediatrics, University of Melbourne, Parkville 3052, Australia.
Centre for Health Analytics, Royal Children's Hospital, Murdoch Childrens Research institute, Department of Paediatrics, University of Melbourne, Parkville 3052, Australia.
出版信息
Lancet Glob Health. 2021 Jul;9(7):e885-e886. doi: 10.1016/S2214-109X(21)00265-5.
Abstract
摘要
相似文献
1
Rotavirus vaccine implementation: evidence to fill the gap?
Lancet Glob Health. 2021 Jul;9(7):e885-e886. doi: 10.1016/S2214-109X(21)00265-5.
2
Update on rotavirus vaccines.
Pediatr Infect Dis J. 2005 Nov;24(11):947-52. doi: 10.1097/01.inf.0000186295.18969.e6.
3
116E rotavirus vaccine may have less impact in India than projected.
Vaccine. 2015 Dec 16;33(51):7142. doi: 10.1016/j.vaccine.2015.08.089.
4
[Vaccine against rotavirus].
Rev Saude Publica. 2006 Apr;40(2):355-8. doi: 10.1590/s0034-89102006000200026. Epub 2006 Mar 29.
5
Rotavirus disease and vaccination: impact on genotype diversity.
Future Microbiol. 2009 Dec;4(10):1303-16. doi: 10.2217/fmb.09.96.
6
Challenges to Developing a Rotavirus Vaccine.
Viral Immunol. 2018 Mar;31(2):104-108. doi: 10.1089/vim.2017.0121. Epub 2017 Dec 21.
7
Rotavirus vaccines at the threshold of implementation in India.
Natl Med J India. 2014 Sep-Oct;27(5):245-8.
8
Impact of rotavirus vaccination: the importance of monitoring strains.
Future Microbiol. 2009 Dec;4(10):1231-4. doi: 10.2217/fmb.09.105.
9
The rotavirus saga revisited.
Annu Rev Med. 2013;64:165-74. doi: 10.1146/annurev-med-121511-093810. Epub 2012 Nov 1.
10
[Italian Pediatrician's consensus statement on anti-Rotavirus vaccines].
Minerva Pediatr. 2008 Feb;60(1):3-16.
引用本文的文献
1
Complete Genome Sequencing of a G3P[14] Rabbit Rotavirus.
Animals (Basel). 2025 May 25;15(11):1548. doi: 10.3390/ani15111548.
2
Vaccine value profile for norovirus.
Vaccine. 2023 Nov 3;41 Suppl 2(Suppl 2):S134-S152. doi: 10.1016/j.vaccine.2023.03.034. Epub 2023 Oct 6.
3
Biolayer Interferometry Analysis for a Higher Throughput Quantification of In-Process Samples of a Rotavirus Vaccine.
Vaccines (Basel). 2022 Sep 21;10(10):1585. doi: 10.3390/vaccines10101585.
本文引用的文献
1
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.
Lancet Glob Health. 2021 Jul;9(7):e942-e956. doi: 10.1016/S2214-109X(21)00167-4. Epub 2021 Apr 20.
2
Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
Pharmacoeconomics. 2021 Jan;39(1):81-97. doi: 10.1007/s40273-020-00986-4. Epub 2020 Nov 24.
3
Intussusception after Rotavirus Vaccine Introduction in India.
N Engl J Med. 2020 Nov 12;383(20):1932-1940. doi: 10.1056/NEJMoa2002276.
4
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
Vaccine. 2020 Feb 5;38(6):1277-1279. doi: 10.1016/j.vaccine.2019.12.014. Epub 2019 Dec 16.
5
Global Routine Vaccination Coverage, 2018.
MMWR Morb Mortal Wkly Rep. 2019 Oct 25;68(42):937-942. doi: 10.15585/mmwr.mm6842a1.
6
Factors Associated With Rotavirus Vaccine Coverage.
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-1824. Epub 2019 Jan 17.
7
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
Value Health. 2016 Dec;19(8):929-935. doi: 10.1016/j.jval.2016.02.017.
8
Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
Trop Med Int Health. 2014 Feb;19(2):177-85. doi: 10.1111/tmi.12233. Epub 2013 Dec 9.
9
A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.
PLoS One. 2012;7(10):e47511. doi: 10.1371/journal.pone.0047511. Epub 2012 Oct 24.
Zotero 插件